0000000000789999

AUTHOR

S. Bolte

showing 2 related works from this author

IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma

2017

0301 basic medicinebusiness.industryMelanomaMutantPhases of clinical researchHematologyFirst in humanmedicine.disease03 medical and health sciences030104 developmental biologyOncologyCancer researchMedicinebusinessAnnals of Oncology
researchProduct

88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast canc…

2020

Oncologymedicine.medical_specialtymedicine.anatomical_structureOncologybusiness.industryInternal medicineT cellmedicineHematologyNeo adjuvantbusinessTriple-negative breast cancerImmune therapyAnnals of Oncology
researchProduct